Study analysis · Nature Communications · 2022
A low-protein diet made male mice live 50% longer—but without one hormone, the same diet made them die younger.
Mice that ate less protein lived longer and stayed healthier, but only if they had a hormone called FGF21; mice missing it got sicker and died earlier on the same diet.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study used mice, not people. The researchers randomly put the mice into groups and gave some a low-protein diet and others a normal diet. They also had mice that were missing a special hormone called FGF21. Because the mice were randomly placed into diet groups, we can say the diet caused the differences we saw in these mice. But we can't be sure the same thing will happen in people.
What’s the bottom line?
Scientists gave some mice food with very little protein and other mice normal food. The mice that ate less protein lived longer and stayed healthier, but only if they had a special hormone called FGF21. Mice without this hormone did not get these benefits and even died earlier on the low-protein diet.
How strong is this study?
The study was well designed because it used many mice, followed them for a long time, and checked lots of things like weight, strength, and how long they lived. However, the mice missing FGF21 came from a different family of mice, which might cause differences unrelated to the diet. Also, they didn't tell us if the people measuring the results knew which diet the mice were on, which could accidentally affect the results.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
73 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=216)+13.2/20
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. The study is a randomized controlled trial in male mice, so it can establish causal relationships between dietary protein restriction and the observed outcomes within this specific experimental model. However, these findings cannot be directly extrapolated to humans without additional evidence. The use of FGF21 knockout mice involves a lifelong genetic manipulation that may have developmental effects, and the wild-type and knockout mice originated from separate colonies, which could introduce confounding factors.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information was provided in the text. The study appears to be an academic investigation without disclosed industry ties, but the lack of disclosure prevents full assessment.
The provided text (title, abstract, intro, results, figure legends) does not include a Conflict of Interest section, funding statement, or author affiliations. Therefore, the presence of any conflicts or industry funding cannot be determined from this text. The severity is marked as 'unknown' due to missing disclosure information.
Key takeaways
- 01
In normal mice, a low-protein diet reduced the risk of death by about half (0.49).
- 02
In mice without FGF21, the same diet increased risk of death (1.60).
- 03
Low-protein mice had less fat, better blood sugar control, and were stronger, but only if they had FGF21.
- 04
This is a study in mice, not humans.
- 05
It suggests FGF21 might be important for how low-protein diets affect aging, but we don't know yet if the same thing happens in people.
Surprising findings
- Low-protein diet increased mortality in FGF21 knockout mice (HR=1.60), reversing the benefit seen in normal mice.Protein restriction is almost universally touted as beneficial; this shows a defined genetic condition can flip it into harm.
- Mice on low protein ate more food but still weighed less and had lower body fat than controls.This contradicts the simple 'calories in, calories out' model—the quality of protein matters more than quantity of food.
- High-fat diet plus low protein protected against obesity in middle-aged mice, normalizing glucose and insulin despite 60% fat.Intuitively, a low-protein high-fat diet seems like junk food, but it prevented metabolic harm.
Practical takeaways
Don't rush to drastically cut protein based on mouse data—think about protein quality and balance, not just quantity.
This is a mouse study; human protein recommendations are different (RDA ~0.8g/kg) and needs vary with age, activity, and health.
low confidenceIf you're older, be especially cautious with low-protein diets because frailty and muscle loss are real risks.
In the study, low protein was beneficial in normal aging mice, but FGF21 knockout mice showed accelerated frailty—genetic differences could affect humans too.
medium confidenceWatch for future research on FGF21 as a potential drug target for metabolic health.
FGF21 levels can be influenced by diet and drugs like metformin; but clinical relevance is still emerging.
medium confidenceWhy this study matters
The 50% Longevity Boost: Low Protein in Mice
Male wild-type mice fed a 5% casein diet had a 51% lower risk of death during the study (hazard ratio 0.49, p=0.008) compared to mice on a 20% casein diet. They also gained less weight, had better glucose control, stronger grip strength, and lower frailty scores at 22 months.
This is one of the strongest effects seen for a dietary intervention on lifespan in mice, and it happened without calorie restriction—mice actually ate more food.
The Jekyll-and-Hyde Hormone: FGF21 Controls Diet Fate
In mice genetically lacking FGF21, the same low-protein diet increased the risk of death by 60% (hazard ratio 1.60, p=0.044). These mice showed earlier age-related weight loss, more frailty, and worse physical performance.
This shows that the same dietary intervention can have completely opposite effects depending on your biology—a classic example of personalized nutrition.
Low Protein Beats High Fat? Middle-Aged Mice Ate 60% Fat and Stayed Lean
When 12-month-old mice were fed a high-fat diet, they gained fat and developed glucose intolerance. But if that high-fat diet also had low protein (5% casein), they stayed lean and had normal glucose and insulin levels—despite eating the same amount of fat.
This challenges the simple 'fat is bad' narrative and highlights the power of protein balance over just cutting calories or fat.
The Beige Fat Thermostat: How Low Protein Turns White Fat into a Fat-Burner
Low-protein diets in wild-type mice dramatically increased expression of Ucp1 and Cidea in inguinal white adipose tissue—genes that turn on thermogenesis and fat burning. This effect was completely absent in FGF21 knockout mice.
It shows a concrete mechanism by which diet can 'brown' white fat, which is a hot topic for metabolism and obesity treatments.
The Danger Zone: When Low Protein Backfires
In FGF21 knockout mice, low protein increased frailty markers (alopecia, coat condition, kyphosis) and caused weight loss starting at 15-18 months instead of 22. By the end, they died significantly earlier than controls.
This is a warning that 'low protein' is not universally healthy—especially for the elderly or those with impaired FGF21 signaling.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave some mice food with very little protein and other mice normal food. The mice that ate less protein lived longer and stayed healthier, but only if they had a special hormone called FGF21. Mice without this hormone did not get these benefits and even died earlier on the low-protein diet.
Research results
In normal mice, a low-protein diet reduced the risk of death by about half (0.49). In mice without FGF21, the same diet increased risk of death (1.60). Low-protein mice had less fat, better blood sugar control, and were stronger, but only if they had FGF21.
What this means - more context
This is a study in mice, not humans. It suggests FGF21 might be important for how low-protein diets affect aging, but we don't know yet if the same thing happens in people.
To determine whether the hormone FGF21 mediates the beneficial effects of dietary protein restriction on lifespan and metabolic health in aging male mice.
Male wild-type mice fed a low-protein (5% casein) diet from 3 months of age lived longer, gained less weight, had better glucose control, improved physical performance, and reduced frailty compared to controls. These benefits were absent in FGF21 knockout mice, which instead showed earlier weight loss, increased frailty, and shortened lifespan when fed the low-protein diet. The study concludes that FGF21 is essential for the anti-aging effects of protein restriction.
Methods Used
Male C57BL/6 wild-type and FGF21 knockout mice were fed control (20% casein) or low-protein (5% casein) diets from 3 months of age. Lifespan was assessed in 30 mice/group; a separate metabolic cohort (12 mice/group) was assessed for body composition, glucose/insulin tolerance, energy expenditure, frailty, and physical performance until 22 months. A third cohort of middle-aged (12-month-old) mice was fed control or low-protein diets with or without 60% fat for 4 months.
Main Finding
Low-protein diet extended lifespan in wild-type mice (hazard ratio 0.49, p=0.008) but shortened lifespan in FGF21 knockout mice (hazard ratio 1.60, p=0.044). Protein restriction reduced body weight, adiposity, frailty, and improved glucose tolerance, insulin sensitivity, and physical performance, all dependent on FGF21. Even in middle-aged mice, low protein prevented high-fat diet-induced obesity and metabolic dysfunction.
Confidence Level
High for male mouse model; limited by use of only males, a single low-protein diet, and non-littermate wild-type vs knockout mice.
Study Flags
Red Flags
- •Only male mice were studied (no females)
- •Wild-type and FGF21 knockout mice were from separate colonies, not littermates
- •Only one low-protein diet formulation (5% casein) was tested
Surprising Findings
Low-protein diet increased mortality in FGF21 knockout mice (HR=1.60), reversing the benefit seen in normal mice.
Protein restriction is almost universally touted as beneficial; this shows a defined genetic condition can flip it into harm.
Practical Takeaways
Don't rush to drastically cut protein based on mouse data—think about protein quality and balance, not just quantity.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Animal RCT
Subject
Lower probability
on the GRADE evidence scale
This study used mice, not people. The researchers randomly put the mice into groups and gave some a low-protein diet and others a normal diet. They also had mice that were missing a special hormone called FGF21. Because the mice were randomly placed into diet groups, we can say the diet caused the differences we saw in these mice. But we can't be sure the same thing will happen in people.
Strengths
- Randomized controlled experimental design with dietary intervention and genetic knockout.
- Large sample size for lifespan study (30 mice per diet/genotype group).
- Long-term follow-up until natural death.
Weaknesses
- Wild-type and FGF21 knockout mice derived from separate colonies, not littermates, which may confound comparisons.
- Unclear blinding for outcome assessment (though some measures were blinded).
- Only male mice studied, limiting generalizability to females.
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave some mice food with very little protein and other mice normal food. The mice that ate less protein lived longer and stayed healthier, but only if they had a special hormone called FGF21. Mice without this hormone did not get these benefits and even died earlier on the low-protein diet.
Research results
In normal mice, a low-protein diet reduced the risk of death by about half (0.49). In mice without FGF21, the same diet increased risk of death (1.60). Low-protein mice had less fat, better blood sugar control, and were stronger, but only if they had FGF21.
What this means - more context
This is a study in mice, not humans. It suggests FGF21 might be important for how low-protein diets affect aging, but we don't know yet if the same thing happens in people.
To determine whether the hormone FGF21 mediates the beneficial effects of dietary protein restriction on lifespan and metabolic health in aging male mice.
Male wild-type mice fed a low-protein (5% casein) diet from 3 months of age lived longer, gained less weight, had better glucose control, improved physical performance, and reduced frailty compared to controls. These benefits were absent in FGF21 knockout mice, which instead showed earlier weight loss, increased frailty, and shortened lifespan when fed the low-protein diet. The study concludes that FGF21 is essential for the anti-aging effects of protein restriction.
Methods Used
Male C57BL/6 wild-type and FGF21 knockout mice were fed control (20% casein) or low-protein (5% casein) diets from 3 months of age. Lifespan was assessed in 30 mice/group; a separate metabolic cohort (12 mice/group) was assessed for body composition, glucose/insulin tolerance, energy expenditure, frailty, and physical performance until 22 months. A third cohort of middle-aged (12-month-old) mice was fed control or low-protein diets with or without 60% fat for 4 months.
Main Finding
Low-protein diet extended lifespan in wild-type mice (hazard ratio 0.49, p=0.008) but shortened lifespan in FGF21 knockout mice (hazard ratio 1.60, p=0.044). Protein restriction reduced body weight, adiposity, frailty, and improved glucose tolerance, insulin sensitivity, and physical performance, all dependent on FGF21. Even in middle-aged mice, low protein prevented high-fat diet-induced obesity and metabolic dysfunction.
Confidence Level
High for male mouse model; limited by use of only males, a single low-protein diet, and non-littermate wild-type vs knockout mice.
Study Flags
Red Flags
- •Only male mice were studied (no females)
- •Wild-type and FGF21 knockout mice were from separate colonies, not littermates
- •Only one low-protein diet formulation (5% casein) was tested
Surprising Findings
Low-protein diet increased mortality in FGF21 knockout mice (HR=1.60), reversing the benefit seen in normal mice.
Protein restriction is almost universally touted as beneficial; this shows a defined genetic condition can flip it into harm.
Practical Takeaways
Don't rush to drastically cut protein based on mouse data—think about protein quality and balance, not just quantity.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Animal RCT
Subject
Lower probability
on the GRADE evidence scale
This study used mice, not people. The researchers randomly put the mice into groups and gave some a low-protein diet and others a normal diet. They also had mice that were missing a special hormone called FGF21. Because the mice were randomly placed into diet groups, we can say the diet caused the differences we saw in these mice. But we can't be sure the same thing will happen in people.
Strengths
- Randomized controlled experimental design with dietary intervention and genetic knockout.
- Large sample size for lifespan study (30 mice per diet/genotype group).
- Long-term follow-up until natural death.
Weaknesses
- Wild-type and FGF21 knockout mice derived from separate colonies, not littermates, which may confound comparisons.
- Unclear blinding for outcome assessment (though some measures were blinded).
- Only male mice studied, limiting generalizability to females.
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study was well designed because it used many mice, followed them for a long time, and checked lots of things like weight, strength, and how long they lived. However, the mice missing FGF21 came from a different family of mice, which might cause differences unrelated to the diet. Also, they didn't tell us if the people measuring the results knew which diet the mice were on, which could accidentally affect the results.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
73 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=216)+13.2/20
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. The study is a randomized controlled trial in male mice, so it can establish causal relationships between dietary protein restriction and the observed outcomes within this specific experimental model. However, these findings cannot be directly extrapolated to humans without additional evidence. The use of FGF21 knockout mice involves a lifelong genetic manipulation that may have developmental effects, and the wild-type and knockout mice originated from separate colonies, which could introduce confounding factors.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information was provided in the text. The study appears to be an academic investigation without disclosed industry ties, but the lack of disclosure prevents full assessment.
The provided text (title, abstract, intro, results, figure legends) does not include a Conflict of Interest section, funding statement, or author affiliations. Therefore, the presence of any conflicts or industry funding cannot be determined from this text. The severity is marked as 'unknown' due to missing disclosure information.